Discontinued — last reported Q3 '23
Philip Morris International Interest Paid remained flat by 0.0% to $422.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.3%, from $389.75M to $422.00M. Over 4 years (FY 2021 to FY 2025), Interest Paid shows an upward trend with a 23.9% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase in interest paid relative to debt levels may signal rising borrowing costs or higher leverage, while a decrease may indicate debt reduction or refinancing at lower rates.
The total cash outflow for interest payments on debt obligations, typically disclosed as a supplemental item in the cash...
Essential for comparing the cost of capital and debt burden across peers in the pharmaceutical industry.
cf_interest_paid| FY'21 | FY'22 | FY'23 | FY'24 | FY'25 | |
|---|---|---|---|---|---|
| Value | $716.00M | $717.00M | $1.34B | $1.56B | $1.69B |
| YoY Change | — | +0.1% | +87.2% | +16.2% | +8.3% |
We use cookies for analytics. See our Privacy and Cookie Policy.